Blood-based CRC test detects adenomas with 90% accuracy — 4 insights

CellMax Life's blood-based cancer detecting test can detect adenomas with close to 90 percent accuracy and cancer at 95 percent accuracy.

What you should know:

1. Researchers administered the test to 737 adults, 50-years or older. About 301 were healthy, 111 had adenomas and 325 were confirmed to have cancer. Researchers confirmed the cancer diagnosis by colonoscopy or tumor biopsy.

2. CellMax will present the study confirming the blood test's accuracy at the ASCO Gastrointestinal Cancer Symposium, Jan. 17-19 in San Francisco.

3. Researchers also discovered that an increase in cell count, was significantly correlated with an increase in disease severity.

4. CellMax Life did not elaborate on what regulatory steps it would pursue next.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

ASC_GI_300x250

Featured Webinars

Featured Whitepapers

Featured Podcast